Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitsumoto, H.
Right arrow Articles by Shungu, D. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mitsumoto, H.
Right arrow Articles by Shungu, D. C.
NEUROLOGY 2007;68:1402-1410
© 2007 American Academy of Neurology

Quantitative objective markers for upper and lower motor neuron dysfunction in ALS

H. Mitsumoto, MD, DSc, A. M. Ulug, PhD, S. L. Pullman, MD, FRCPC, C. L. Gooch, MD, S. Chan, MD, MPH, MBA, M. -X. Tang, PhD, X. Mao, MS, A. P. Hays, MD, A. G. Floyd, BA, V. Battista, BA, J. Montes, RPT, MA, S. Hayes, RPT, MA, S. Dashnaw, P. Kaufmann, MD, MSc, P. H. Gordon, MD, J. Hirsch, PhD, B. Levin, PhD, L. P. Rowland, MD and D. C. Shungu, PhD

From the Eleanor and Lou Gehrig MDA/ALS Research Center (H.M., V.B., J.M., P.K., P.H.G., L.P.P.) and Department of Neurology (H.M., S.L.P., C.L.G., A.G.F., V.B., J.M., S.H., P.K., P.H.G., L.P.R.), Columbia University, and Department of Radiology (S.C.), Sergievsky Center (M.-X.T.), Department of Pathology (Neuropathology) (A.P.H.), Functional MRI Center (J.H., S.D.), Department of Radiology, and Department of Biostatistics (M.-X.T., B.L.), Mailman School of Public Health, Columbia University, and Department of Radiology (A.M.U., X.M., D.C.S.), Weill Medical College of Cornell University, New York, NY.

Address correspondence and reprint requests to Dr. H. Mitsumoto, Eleanor and Lou Gehrig MDA/ALS Research Center, Neurological Institute, Columbia University, 710 W. 168 St., New York, NY 10032 hm246{at}columbia.edu

Objective: To investigate the value of objective biomarkers for upper (UMN) and lower (LMN) motor neuron involvement in ALS.

Methods: We prospectively studied 64 patients with ALS and its subsets using clinical measures, proton MR spectroscopic imaging (1H MRSI), diffusion tensor imaging, transcranial magnetic stimulation, and the motor unit number estimation (MUNE) at baseline and every 3 months for 15 months and compared them with control subjects.

Results: 1H MRSI measures of the primary motor cortex N-acetyl-aspartate (NAA) concentration were markedly reduced in ALS (p = 0.009) and all UMN syndromes combined (ALS, familial ALS [fALS], and primary lateral sclerosis; p = 0.03) vs control values. Central motor conduction time to the tibialis anterior was prolonged in ALS (p < 0.0005) and combined UMN syndromes (p = 0.001). MUNE was lower in ALS (p < 0.0005) and all LMN syndromes combined (ALS, fALS, and progressive muscular atrophy; p = 0.001) vs controls. All objective markers correlated well with the ALS Functional Rating Scale–Revised, finger and foot tapping, and strength testing, suggesting these markers related to disease activity. Regarding changes over time, MUNE changed rapidly, whereas neuroimaging markers changed more slowly and did not significantly differ from baseline.

Conclusions: 1H MR spectroscopic imaging measures of the primary motor cortex N-acetyl-aspartate (NAA) concentration and ratio of NAA to creatine, central motor conduction time to the tibialis anterior, and motor unit number estimation significantly differed between ALS, its subsets, and control subjects, suggesting they have potential to provide insight into the pathobiology of these disorders.


Supplemental data at www.neurology.org

Received June 29, 2006. Accepted in final form December 20, 2006.

Disclosure: The authors report no conflicts of interest.




This article has been cited by other articles:


Home page
NeurologyHome page
R. M. Mitchell, W. M. Freeman, W. T. Randazzo, H. E. Stephens, J. L. Beard, Z. Simmons, and J. R. Connor
A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis
Neurology, January 6, 2009; 72(1): 14 - 19.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M L Stromillo, M T Dotti, M Battaglini, M Mortilla, S Bianchi, K Plewnia, L Pantoni, D Inzitari, A Federico, and N De Stefano
Structural and metabolic brain abnormalities in preclinical cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy
J. Neurol. Neurosurg. Psychiatry, January 1, 2009; 80(1): 41 - 47.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
F Agosta, M A Rocca, P Valsasina, S Sala, D Caputo, M Perini, F Salvi, A Prelle, and M Filippi
A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients
J. Neurol. Neurosurg. Psychiatry, January 1, 2009; 80(1): 53 - 55.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. Nelles, W. Block, F. Traber, U. Wullner, H.H. Schild, and H. Urbach
Combined 3T Diffusion Tensor Tractography and 1H-MR Spectroscopy in Motor Neuron Disease
AJNR Am. J. Neuroradiol., October 1, 2008; 29(9): 1708 - 1714.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by AAN Enterprises, Inc.